Litcius/Paper detail

Publisher Correction: Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

Mark J. Mulligan, Kirsten E. Lyke, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, Kathleen M. Neuzil, Vanessa Raabe, Ruth Bailey, Kena A. Swanson, Ping Li, Kenneth Koury, Warren V. Kalina, David Cooper, Camila R. Fontes-Garfias, Pei‐Yong Shi, Özlem Türeci, Kristin R. Tompkins, Edward E. Walsh, Robert W. Frenck, Ann R. Falsey, Philip R. Dormitzer, William C. Gruber, Uğur Şahin, Kathrin U. Jansen

2021Nature28 citationsDOIOpen Access PDF

Topics & Concepts

Coronavirus disease 2019 (COVID-19)VirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakComputational biologyBiologyMedicineInternal medicineOutbreakInfectious disease (medical specialty)DiseaseCircular RNAs in diseases
Publisher Correction: Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults | Litcius